These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 17931455)

  • 1. Marrow proliferation as a cause of hearing loss in beta-thalassaemia major.
    Thio D; Prasad V; Anslow P; Lennox P
    J Laryngol Otol; 2008 Nov; 122(11):1253-6. PubMed ID: 17931455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Desferrioxamine ototoxicity in an adult transfusion-dependent population.
    Chiodo AA; Alberti PW; Sher GD; Francombe WH; Tyler B
    J Otolaryngol; 1997 Apr; 26(2):116-22. PubMed ID: 9106087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful desensitization of a case with desferrioxamine hypersensitivity.
    Gülen F; Demir E; Tanaç R; Aydinok Y; Gulen H; Yenigün A; Can D
    Minerva Pediatr; 2006 Dec; 58(6):571-4. PubMed ID: 17093379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensory neural hearing loss in beta-thalassemia major patients treated with deferoxamine.
    Shamsian BS; Aminasnafi A; Moghadassian H; Gachkar L; Arzanian MT; Alavi S; Esfehani H; Garallahi F; Amini R
    Pediatr Hematol Oncol; 2008 Sep; 25(6):502-8. PubMed ID: 18728969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long term audiological evaluation of beta-thalassemic patients.
    Kontzoglou G; Koussi A; Economou M; Tsatra I; Perifanis V; Noussios G; Athanassiou-Metaxa M
    Acta Otorhinolaryngol Belg; 2004; 58(2):113-7. PubMed ID: 15515654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined therapy of silymarin and desferrioxamine in patients with beta-thalassemia major: a randomized double-blind clinical trial.
    Gharagozloo M; Moayedi B; Zakerinia M; Hamidi M; Karimi M; Maracy M; Amirghofran Z
    Fundam Clin Pharmacol; 2009 Jun; 23(3):359-65. PubMed ID: 19453758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bilateral auditory ossicular expansions in a child with beta-thalassemia major: Case report and literature review.
    Sirisena M; Birman CS; McKibbin AJ; O'Brien KJ
    Int J Pediatr Otorhinolaryngol; 2018 Sep; 112():126-131. PubMed ID: 30055721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compliance of deferoxamine injection in beta-thalassaemia major patients in Iran.
    Rashid M; Karimi M
    Transfus Med; 2012 Apr; 22(2):104-7. PubMed ID: 22212011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality of life in transfusion-dependent thalassaemia patients on desferrioxamine treatment.
    Dahlui M; Hishamshah MI; Rahman AJ; Aljunid SM
    Singapore Med J; 2009 Aug; 50(8):794-9. PubMed ID: 19710979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe infections in thalassaemic patients: prevalence and predisposing factors.
    Rahav G; Volach V; Shapiro M; Rund D; Rachmilewitz EA; Goldfarb A
    Br J Haematol; 2006 Jun; 133(6):667-74. PubMed ID: 16704445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Long-term follow-up and bone imaging in acquired osteochondrodysplasia in a female patient with thalassemia and desferrioxamine hypersensitivity].
    Mangiagli A; De Sanctis V; Campisi S; Di Silvestro G; Urso L
    Minerva Pediatr; 2000 Apr; 52(4):235-41. PubMed ID: 11995208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hepatic abscess due to Yersinia in a child with thalassemia].
    Brunel F; François P; Durand C; Croize J; Jeannoel P
    Pediatrie; 1993; 48(2):159-62. PubMed ID: 8393182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid development of severe toxic retinopathy associated with continuous intravenous deferoxamine infusion.
    Lai TY; Lee GK; Chan WM; Lam DS
    Br J Ophthalmol; 2006 Feb; 90(2):243-4. PubMed ID: 16424543
    [No Abstract]   [Full Text] [Related]  

  • 14. Audiological evaluation in adult beta-thalassemia major patients under regular chelation treatment.
    Ambrosetti U; Dondè E; Piatti G; Cappellini MD
    Pharmacol Res; 2000 Nov; 42(5):485-7. PubMed ID: 11023713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of deferoxamine (DFO) in transfusion-dependent β-thalassemia during pregnancy: A retrospective study.
    Piccioni MG; Capone C; Vena F; Del Negro V; Schiavi MC; D'Ambrosio V; Giancotti A; Smacchia MP; Brunelli R
    Taiwan J Obstet Gynecol; 2020 Jan; 59(1):120-122. PubMed ID: 32039778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of desferrioxamine ototoxicity in thalassemic patients. Follow-up over a 5-year period and results].
    Sacco M; Meleleo D; Tricarico N; Greco Miani A; Serra E; Parlatore L
    Minerva Pediatr; 1994 May; 46(5):225-30. PubMed ID: 8090141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Major sickle cell anaemia and hypoacusia: about 112 cases in Yopougon, Côte d'Ivoire].
    Elola A; Hien FM; Ouattara M; FataoFataho B; Kouassi B
    Bull Soc Pathol Exot; 2009 Aug; 102(3):173-4. PubMed ID: 19739413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac disease in beta-thalassaemia major: Is it reversible?
    Atiq M; Bana M; Ahmed US; Bano S; Yousuf M; Fadoo Z; Khurshid M
    Singapore Med J; 2006 Aug; 47(8):693-6. PubMed ID: 16865210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spermatogenesis in young adult patients with beta-thalassaemia major long-term treated with desferrioxamine.
    De Sanctis V; Borsari G; Brachi S; Govoni M; Carandina G
    Georgian Med News; 2008 Mar; (156):74-7. PubMed ID: 18403814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Audiologic evaluation of patients with thalassemic syndromes treated with desferrioxamine B].
    Gaini RM; Moretti E; Boffa C; Terzoli S; Carnelli V
    Pediatr Med Chir; 1988; 10(5):503-4. PubMed ID: 3241755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.